Publications by authors named "Ronald F van Vollenhoven"

100Publications

Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls.

Rheumatology (Oxford) 2020 Jul 12. Epub 2020 Jul 12.

Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keaa267DOI Listing
July 2020

Assessing joint inflammation-a way forward for SLE trials?

Rheumatology (Oxford) 2019 08;58(8):1327-1328

Rheumatology and Clinical Immunology, Amsterdam UMC, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kez131DOI Listing
August 2019

Methotrexate for Prevention of Cardiovascular Events.

N Engl J Med 2019 06;380(23):2276-2277

Amsterdam University Medical Centers, Amsterdam, the Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1905061DOI Listing
June 2019

Dynamics of the Type I Interferon Response During Immunosuppressive Therapy in Rheumatoid Arthritis.

Front Immunol 2019 24;10:902. Epub 2019 Apr 24.

Amsterdam UMC, Vrije Universiteit Amsterdam, Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2019.00902DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491736PMC
April 2019

Construction of a Frailty Index as a Novel Health Measure in Systemic Lupus Erythematosus.

J Rheumatol 2020 01 15;47(1):72-81. Epub 2019 Apr 15.

From the Divisions of Rheumatology and Geriatric Medicine, Department of Medicine, Dalhousie University; Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia; Divisions of Rheumatology and Clinical Epidemiology, Department of Medicine, McGill University, Montreal; Division of Rheumatology, Centre Hospitalier Universitaire (CHU) de Québec et Université Laval, Quebec City, Quebec; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario; University of Manitoba, Winnipeg, Manitoba; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham; Arthritis Research UK Epidemiology Unit, Faculty of Biology Medicine and Health, Manchester Academic Health Sciences Center, The University of Manchester, and National Institute for Health Research (NIHR) Manchester Musculoskeletal Biomedical Research Centre, Manchester University National Health Service (NHS) Foundation Trust, Manchester Academic Health Science Center, Manchester; Center for Rheumatology, Department of Medicine, University College London, London; Lanarkshire Center for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland; Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, London, UK; Instituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico; Cedars-Sinai/David Geffen School of Medicine at University of California Los Angeles (UCLA), Los Angeles, California; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Department of Medicine, State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, North Carolina; Northwestern University and Feinberg School of Medicine, Chicago, Illinois; Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, Pennsylvania; Feinstein Institute for Medical Research, Manhasset, New York; Emory University School of Medicine, Division of Rheumatology, Atlanta, Georgia; Medical University of South Carolina, Charleston, South Carolina; University of California San Diego School of Medicine (UCSD), La Jolla, California; Hospital for Joint Diseases, New York University (NYU), Seligman Center for Advanced Therapeutics, New York, New York, USA; Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo; Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Unit for Clinical Therapy Research (ClinTRID), Karolinska Institute, Stockholm; Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden; Copenhagen Lupus and Vasculitis Clinic, Section 4242, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.181338
Publisher Site
http://dx.doi.org/10.3899/jrheum.181338DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800806PMC
January 2020

Serum Biomarkers for Prediction of Response to Methotrexate Monotherapy in Early Rheumatoid Arthritis: Results from the SWEFOT Trial.

J Rheumatol 2019 06 1;46(6):555-563. Epub 2019 Feb 1.

From the Rheumatology Unit, Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; Crescendo Bioscience, South San Francisco, California, USA; Section of Rheumatology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Amsterdam Rheumatology and Immunology Center, Amsterdam, the Netherlands; Institute of Environmental Medicine (IMM), Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.180537
Publisher Site
http://dx.doi.org/10.3899/jrheum.180537DOI Listing
June 2019

Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay.

Sci Transl Med 2019 01;11(477)

Department of Immunopathology, Sanquin Research, 1066 CX Amsterdam, Netherlands, and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands.

View Article

Download full-text PDF

Source
http://stm.sciencemag.org/lookup/doi/10.1126/scitranslmed.aa
Publisher Site
http://dx.doi.org/10.1126/scitranslmed.aat3356DOI Listing
January 2019

Clinical SLEDAI-2K zero may be a pragmatic outcome measure in SLE studies.

Expert Opin Biol Ther 2019 02 27;19(2):157-168. Epub 2018 Dec 27.

a Division of Rheumatology, Department of Medicine , Karolinska Institutet , Stockholm , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2019.1561856DOI Listing
February 2019

The relationship between remission and health-related quality of life in a cohort of SLE patients.

Rheumatology (Oxford) 2019 04;58(4):628-635

Department of Rheumatology, Amsterdam Rheumatology and immunology Center, VU University Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
https://academic.oup.com/rheumatology/article/58/4/628/52308
Publisher Site
http://dx.doi.org/10.1093/rheumatology/key349DOI Listing
April 2019

Long-Term Dietary Changes after Diagnosis of Rheumatoid Arthritis in Swedish Women: Data from a Population-Based Cohort.

Int J Rheumatol 2018 11;2018:9152480. Epub 2018 Jun 11.

Eugeniahemmet, T2, Karolinska Universitetssjukhuset, Solna, 17176 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/9152480DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016163PMC
June 2018

Evolution of clinical trials for rheumatoid arthritis and spondyloarthritis.

Curr Opin Rheumatol 2018 07;30(4):340-346

Clinical Immunology & Rheumatology, Amsterdam Rheumatology and immunology Center, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/BOR.0000000000000516DOI Listing
July 2018

Rheumatologists' guideline adherence in rheumatoid arthritis: a randomised controlled study on electronic decision support, education and feedback.

Clin Exp Rheumatol 2018 Jan-Feb;36(1):21-28. Epub 2017 Jun 5.

Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
April 2018

Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort.

Lupus Sci Med 2017 8;4(1):e000192. Epub 2017 Feb 8.

Division of Rheumatology , School of Medicine, Johns Hopkins University , Baltimore, MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/lupus-2016-000192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307372PMC
February 2017

Editorial: Who Gets Lupus? Clues to a Tantalizing Syndrome.

Arthritis Rheumatol 2017 03;69(3):483-486

Amsterdam Rheumatology and Immunology Center ARC, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.40005DOI Listing
March 2017

Early treatment intensification induces favourable radiographic outcomes according to predicted versus observed radiographic progression in early rheumatoid arthritis: a subanalysis of the randomised FIN-RACo and NEO-RACo trials.

Clin Exp Rheumatol 2016 Nov-Dec;34(6):1065-1071. Epub 2016 Aug 31.

Department of Internal Medicine, Centre for Rheumatic Diseases, Tampere University Hospital; and School of Medicine, University of Tampere, Finland.

View Article

Download full-text PDF

Source
June 2017

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab.

RMD Open 2016 10;2(1):e000213. Epub 2016 May 10.

Karolinska Institute, Stockholm, Sweden; Amsterdam Rheumatology and Immunology Center ARC Academic Medical Center, Amsterdam.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/rmdopen-2015-000213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874056PMC
June 2016

New therapeutic approaches in rheumatoid arthritis.

Presse Med 2016 Jun 27;45(6 Pt 2):e179-92. Epub 2016 May 27.

Department of Medicine, Karolinska Institute, Unit for Clinical Research Therapy, Inflammatory Diseases (ClinTrid), D1:00, Karolinska Universitetssjukhustet 171 76, Stockholm, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2016.05.004DOI Listing
June 2016

Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial.

RMD Open 2016 1;2(1):e000197. Epub 2016 Mar 1.

Unit of Clinical Therapy Research, Inflammatory Diseases (ClinTRID), Department of Medicine , Karolinska Institutet, Karolinska University Hospital , Stockholm , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/rmdopen-2015-000197DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780313PMC
March 2016

Reply.

Arthritis Care Res (Hoboken) 2016 07;68(7):1051

Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.22809DOI Listing
July 2016

Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices.

J Rheumatol 2015 Dec 1;42(12):2288-95. Epub 2015 Nov 1.

From the Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; New York University Langone Medical Center; Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center, New York; Hofstra North Shore-LIJ School of Medicine, Hempstead, New York; Medical University of South Carolina, Charleston, South Carolina; Temple University School of Medicine, Philadelphia, Pennsylvania; Johns Hopkins University School of Medicine, Baltimore, Maryland; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Karolinska University Hospital, Stockholm, Sweden; Cedars-Sinai Medical Center, Los Angeles, California, USA.J.S. Hui-Yuen, MD, MSc, Fellow, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; A. Reddy, BSc, Research Assistant, New York University Langone Medical Center; J. Taylor, MD, Pediatric Resident, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; X. Li, BSc, Research Assistant, Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center; A.H. Eichenfield, MD, Assistant Professor, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; L.M. Bermudez, MD, Fellow, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; A.J. Starr, MD, Assistant Professor, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; L.F. Imundo, MD, Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center; J. Buyon, MD, Professor, New York University Langone Medical

View Article

Download full-text PDF

Source
http://www.jrheum.org/cgi/doi/10.3899/jrheum.150470
Publisher Site
http://dx.doi.org/10.3899/jrheum.150470DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031077PMC
December 2015

Remission in SLE: closing in on the target.

Ann Rheum Dis 2015 Dec 28;74(12):2103-6. Epub 2015 Oct 28.

Center for Autoimmune and Musculoskeletal, The Feinstein Institute for Medical Research, Manhasset, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2015-208231DOI Listing
December 2015

Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial.

BMC Med 2015 Sep 30;13:247. Epub 2015 Sep 30.

Department of Rheumatology and Inflammation Research, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12916-015-0485-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589197PMC
September 2015

Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction or discontinuation in rheumatoid arthritis.

Ann Rheum Dis 2015 Dec 4;74(12):2260-1. Epub 2015 Sep 4.

Department of Pharmacy, Sint Maartenskliniek, Nijmegen, The Netherlands Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2015-207814DOI Listing
December 2015

Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 Years.

J Rheumatol 2015 Oct 15;42(10):1761-6. Epub 2015 Aug 15.

From the Unit for Clinical Therapy Research, Inflammatory Diseases, Karolinska Institute, Stockholm, Sweden; Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas; Department of Rheumatology, University of California, Los Angeles Medical Center, Los Angeles, California, USA; Roche Products Ltd., Welwyn Garden City, UK.R.F. van Vollenhoven, MD, Chief of the Unit for Clinical Therapy Research, Inflammatory Disease, Karolinska Institute; R.M. Fleischmann, MD, Clinical Professor of Medicine, Department of Internal Medicine, University of Texas, Southwestern Medical Center; D.E. Furst, MD, Carl M. Pearson Professor of Medicine, Department of Rheumatology, University of California, Los Angeles Medical Center; S. Lacey, MSc, Statistician, Roche Products Ltd.; P.B. Lehane, PhD, Senior Clinical Development Scientist, Roche Products Ltd.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.150051
Publisher Site
http://dx.doi.org/10.3899/jrheum.150051DOI Listing
October 2015

Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?

Arthritis Res Ther 2015 Aug 3;17:181. Epub 2015 Aug 3.

Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, 17176, Sweden.

View Article

Download full-text PDF

Source
http://arthritis-research.com/content/17/1/181
Publisher Site
http://dx.doi.org/10.1186/s13075-015-0707-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522973PMC
August 2015

Rituximab and lupus--a promising pair?

Curr Rheumatol Rep 2014 ;16(9):444

Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), Karolinska Institute, 171 76, Stockholm, Sweden,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11926-014-0444-5DOI Listing
February 2015

Tofacitinib versus methotrexate in rheumatoid arthritis.

N Engl J Med 2014 Jun;370(25):2377-86

From Seoul National University College of Medicine, Seoul, South Korea (E.B.L.); Metroplex Clinical Research Center, Dallas (R.F.); Cabrini Health and Monash University, Melbourne, VIC, Australia (S.H.); Pfizer, Groton, CT (B.W., J.D.B., D.G., S.K., G.V.W., C.Z., S.H.Z.); Pfizer, New York (T.K.); and Karolinska Institute, Stockholm (R.F.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1310476DOI Listing
June 2014

Advances in the treatment of rheumatoid arthritis.

F1000Prime Rep 2014 6;6:31. Epub 2014 May 6.

Department of Medicine, Unit of Clinical Therapy Research in Inflammatory Diseases (ClinTRID) Karolinska University Hospital, D2:00, 171 76 Stockholm Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12703/P6-31DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017904PMC
June 2014